📍Spotlight on Dr. Mohannad Abu-Hilal
Associate Professor and Head of Dermatology at McMaster University, where he leads the Advanced Clinical Dermatology Fellowship and is committed to medical education. His work focuses on CTCL, atopic dermatitis, prurigo nodularis, and immunobullous diseases.

Spotlight on Dr. Steven T. Rosen: Physician, Scientist, Poet. Executive VP and Director Emeritus of the Beckman Research Institute at City of Hope, he is a leading researcher in hematologic malignancies with 500+ publications. Creator of Heartfelt Reflections (poetry anthology) and Lover (album). 

📍Spotlight on Dr. Jennifer Teichman, MD, MSc

A lymphoma specialist at the Odette Cancer Centre and an Assistant Professor at the University of Toronto, she focuses on advanced cutaneous T cell lymphoma and is dedicated to improving hematology training to keep pace with evolving treatments.

🌟 Spotlight on CTCL Expert Dr. Martine Bagot, MD, PhD

Professor and Head of Dermatology at Hôpital Saint Louis, Paris, Dr. Bagot co-directs INSERM Unit 976 and leads the French Cutaneous Lymphoma Group. A global CTCL authority, she has authored 750+ papers in dermatology, immunology, and oncology.

Spotlight on ISCL Board Member Dr. Jade Cury Martins, MD, PhD
Professor of Dermatology at the University of São Paulo, Dr. Martins specializes in oncodermatology and cutaneous lymphomas. Her research explores tumor immunology, NK cells, and novel CTCL therapies.
🔗 lattes.cnpq.br/503793454157...

⭐ Spotlight on ISCL Board Member Youn H. Kim, MD

Dr. Kim, the Joanne and Peter Haas Jr. Professor at Stanford, directs the Multidisciplinary Cutaneous Lymphoma Clinic. A leader in CTCL research, she has advanced clinical trials, biomarkers, and novel therapies.

🔗 med.stanford.edu/profiles/y...

Spotlight on ISCL Board Member Dr. Pablo L. Ortiz-Romero, MD, PhD — Professor and Head of Dermatology at Hospital 12 de Octubre, Universidad Complutense de Madrid. A leader in CTCL research, he pioneers CTCL care in Spain, conducts European trials, and serves on the ISCL and EORTC CLTG boards.

Spotlight on ISCL Board Member Dr. Christiane Querfeld, MD, PhD – Professor and Director, Cutaneous Lymphoma Program, City of Hope. Expert in CTCL, immune checkpoints, and immunotherapy. Passionate about research, patients, mentoring, and exploring the world.
🔗 www.cityofhope.org/patients...

Spotlight on ISCL Board Member Dr. Yang Wang, MD, PhD — Chair and Professor of Dermatology at Peking University First Hospital, Beijing. Passionate physician-scientist and award-winning researcher, she built China’s largest CTCL cohort and national registry. 🔗 www.researchgate.net/profile/Yang...

📍Spotlight on ISCL Treasurer Dr. Ivan Litvinov
Associate Professor of Dermatology at McGill University, he leads research in cutaneous lymphoma/oncology and care for Northern Indigenous communities. He is currently involved in organizing the 6th WCCL in Montreal.
🔗 www.mcgill.ca/expmed/dr-iva...

Prof. Dr. Rudolf Stadler, Head of Dermatopathology at Ruhr University Bochum, is a leader in dermato-oncology and CTCL research. Former EORTC CTCL chair and German Dermatological Society president, he advances lymphoma therapy and fosters global collaboration through ISCL.

🌟 Spotlight on ISCL President Dr. Julia Scarisbrick 🌟
Consultant dermatologist & Professor at the University of Birmingham, she leads global cutaneous lymphoma research, co-leads the PROCLIPI study, and is dedicated to improving patient survival & quality of life.
🔗 www.birmingham.ac.uk/staff/...

Save the date for the 6th World Congress of Cutaneous Lymphomas (6WCCL), June 25–27, 2026. Hosted by ISCL, USCLC & EORTC CLTG. Featuring leading research, lectures, and abstracts on all aspects of cutaneous lymphomas. More info: 6wccl.org